[1] |
Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within anca-associated vasculitis[J]. N Engl J Med, 2012, 367(3): 214-223.
|
[2] |
Bate S, Mcgovern D, Costigliolo F, et al. The improved kidney risk score in anca-associated vasculitis for clinical practice and trials[J]. J Am Soc Nephrol, 2024, 35(3): 335-346.
|
[3] |
Farrukh L, Mumtaz A, Sami F, et al. Familial association of granulomatosis with polyangiitis: a case-based review of literature[J]. Cureus, 2023, 15(6): e40786.
|
[4] |
Gomes AM, Nery F, Ventura A, et al. Familial clusters of ANCA small-vessel vasculitis[J]. NDT plus, 2009, 2(1): 34-35.
doi: 10.1093/ndtplus/sfn165
pmid: 25949281
|
[5] |
Zhang P, Yao J, Gao CL, et al. Validation of a renal risk score in a cohort of children with anca-associated glomerulonephritis[J]. J Investig Med, 2023, 71(8): 854-864.
|
[6] |
华胄, 马雁鸿, 陈亮亮, 等. 伴肾小球IgA沉积的抗中性粒细胞胞浆抗体相关性小血管炎的分析[J]. 中华肾脏病杂志, 2018, 34(3): 173-178.
doi: 10.3760/cma.j.issn.1001-7097.2018.03.003
|
|
Hua Z, Ma YH, Chen LL, et al. Clinicopathological features of antineutrophil cytoplasmic antibodies associated vasculitis with glomerular IgA deposits[J]. Zhonghua Shenzangbing Zazhi, 2018, 34(3): 173-178.
|
[7] |
Lin W, Shen C, Zhong Y, et al. Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival[J]. Front Immunol, 2021, 12: 625672.
|
[8] |
Neumann I, Birck R, Newman M, Schnülle P, et al. SCG/Kinjoh mice: a model of anca-associated crescentic glomerulonephritis with immune deposits[J]. Kidney Int, 2003, 64(1): 140-148.
pmid: 12787404
|
[9] |
Bantis C, Stangou M, Schlaugat C, et al. Is presence of anca in crescentic iga nephropathy a coincidence or novel clinical entity? a case series[J]. Am J Kidney Dis, 2010, 55(2): 259-268.
doi: 10.1053/j.ajkd.2009.09.031
pmid: 20042261
|
[10] |
王培培, 张沛, 高春林, 等. 补体参与儿童肾脏疾病发病机制的再认识[J]. 临床儿科杂志, 2024, 42(5): 467-473.
|
|
Wang PP, Zhang P, Gao CL, et al. Re-recognition of the complement involvement in the pathogenesis of kidney diseases in children[J]. Linchuang Erke Zazhi, 2024, 42(5): 467-473.
|
[11] |
Chen M, Jayne Drw, Zhao MH. Complement in anca-associated vasculitis: mechanisms and implications for management[J]. Nat Rev Nephrol, 2017 ;13(6):359-367.
|
[12] |
Yu F, Chen M, Wang S-X, et al. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney[J]. Nephrology (Carlton, Vic.), 2007, 12(1):74-80.
|
[13] |
罗丹, 郑智勇. ANCA相关性肾炎合并IgA肾病3例临床病理分析[J]. 诊断病理学杂志, 2016, 23(12): 927-929,935.
|
|
Luo D, Zheng ZY. ANCA-associated glomerulonephritis combined with IgA nephropathy: a clinicopathological analysis of thress cases[J]. Zhenduan Binglixue Zazhi, 2016, 23(12): 927-929,935.
|
[14] |
杨丹, 何志军, 谢永新, 等. ANCA相关性血管炎肾损害合并IgA肾病2例临床病理分析[J]. 诊断病理学杂志, 2022, 29(9): 855-857.
|
|
Yang D, He ZJ, Xie YX, et al. ANCA-associated glomerulonephritis combined with IgA nephropathy: a clinicopathological analysis of thress cases[J]. Zhenduan Binglixue Zazhi, 2022, 29(9): 855-857.
|
[15] |
Osman MS, Tervaert JWC. Anti-neutrophil cytoplasmic antibodies (ANCA) as disease activity biomarkers in a “personalized medicine approach” in ANCA-associated vasculitis[J]. Curr Rheumatol Rep, 2019, 21(12): 76.
|